BiomarkersHumans
Midlife to Late‐Life Changes in Plasma Biomarkers of Alzheimer's Disease Pathology and Neurodegeneration and Associations with 5‐Year Cognitive Change in Late‐Life: The Atherosclerosis Risk in Communities (ARIC) Study
AAIC 2025 Abstract
Abstract
Background: Plasma biomarkers of Alzheimer's disease (AD) pathology and neurodegeneration provide a non‐invasive method to assess brain pathology associated with dementia and cognitive decline.
The paper
Priya Palta, James Russell Pike, Yifei Lu, Josef Coresh
Show 11 more authors
Keenan A. Walker, Kevin J. Sullivan, Gwen Gwen Windham, Bharat Thyagarajan, Michelle M Mielke, Pamela L. Lutsey, Timothy M. Hughes, David S. Knopman, A. Richey Sharrett, Rebecca F. Gottesman, Thomas H. Mosley,University of North Carolina at Chapel Hill · New York University
AAIC 2025 Abstract · 8 Jan 2026 · CC BY
Presented at AAIC 2025
